Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT05124704 |
| Other study ID # |
IRB-2021-214 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
N/A
|
| First received |
|
| Last updated |
|
| Start date |
July 1, 2021 |
| Est. completion date |
November 5, 2021 |
Study information
| Verified date |
January 2022 |
| Source |
Zhejiang Cancer Hospital |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Interventional
|
Clinical Trial Summary
The beneficial of perioperative usage of thoracic epidural anesthesia and analgesia in
various thoracic and upper abdominal surgery are well studied. However, intraoperative data
are lacking whether combined thoracic epidural and general anesthesia have effect on the
median (50%) effective effect-concentration (EC50) of propofol for inducing loss of
consciousness (LOC). We performed this study among patients undergoing open gastrectomy in
gastric cancer patients.
Sixty patients undergoing open gastrectomy were randomly assigned to two groups with thoracic
combined general anesthesia (TEA+GA) or general anesthesia (GA) alone. Target-controlled
infusion (TCI) of propofol was used for anesthesia induction. The initial propofol
concentration of target effect-site (Ceprop) was 3.5 ug/ml and was increased stepwise by
0.5ug/ml at each 4 min intervals by an un-down sequential method to reach LOC. The predicted
Ceprop at the time of LOC, intravenous anesthetics, vasopressor requirement, emergency time
from anesthesia and postoperative numeric rating scale (NRS) were recorded and analyzed
between two groups.
Description:
After received the approvement of ethics committee of the Cancer Hospital of the University
of Chinese Academy of Sciences (approval number IRB- 2021-214). 60 adult gastric cancer
patients between 18-75 yrs, ASA physical state I and II, undergoing open gastrectomy, were
enrolled in this study. The exclusion criteria included: patients with contraindications to
epidural puncture or catheter placement; chronic or acute (within 48 h) intake of
psychotropic drugs, benzodiazepines, anticonvulsants, or opioids; alcoholism; hepatic, renal,
neurological or other organ dysfunction; younger than 18 years or older than 75 years; with
allergic to local anesthetic solutions or opioids; received neo-adjuvant chemotherapy; as
well as patients who refuse to receive epidural puncture.
Patients were randomly assigned to either TEA+GA group of GA group. The requirement for the
modified up-down method was used to confirm sample size (1).
Preoperative arrangements 3-lead electrocardiogram, pulse oximetry and continuously invasive
artery blood pressure via left radial artery() were measured for basic monitoring. A central
venous catheter was placed in the right internal jugular vein for fluid input and central
venous pressure measurement and its position was confirmed by ultrasound. Bispectral Index
(BIS) monitor (VT94306, Aspect VISTA, Covidien IIc, MA, USA) was measured for monitoring the
depth of anesthetic.
Thoracic Epidural Anesthesia Epidural puncture was performed in the left lateral position
through the interspace between the eighth to ninth thoracic vertebra (T8-T9). Epidural
catheter was inserted by median approach using "loss-of-resistance"technique and was placed
advanced 4 cm cephalad. A test dose of 3ml, 1%, lidocaine was injected through the catheter
after the aspiration test for blood and cerebrospinal fluid shows negative results. Non
sensory and motor anesthesia after 4 min of test dose injection indicate the absence of
accidental subarachnoid placement of the catheter. In group TEA+GA, 5-8ml of 0.375%
ropivacaine depend on the height and weight of the patient was administrated through the
epidural catheter at least 20 min before induction, by the second anesthesiologist, to obtain
a bilateral segmentary sensory block to pinprick between T4 and T12 dermatomes. Continuous
infusion of 4-6 ml 0.375% ropivacaine was applied using micro-infusion pump after
induction(2). In group GA, same dose of normal saline was administered before induction and
during surgery.
General Anesthesia General anesthesia was induced by propofol plasma target-controlled
infusion (TCI) (). To explore the EC50 of propofol for inducing LOC in two groups. We started
induction using a series of predicted effect-site concentrations of propofol (Ceprop) with an
equal step wise of 0.5 ug/ml, according to the up-down method of Dixon(1). The initial Ceprop
for the first patient of each group was 3.5 ug/ml based on previous studies (3) . Positive
response to propofol was defined as LOC happened within 4 min after start of TCI under
initial concentration. Otherwise the response was taken as negative and propofol
concentration was increased 0.5 ug/ml more each 4 min until patient reach LOC (LOC was
defined as loss of response to verbal commands). The initial TCI Ceprop was increased by 0.5
ug/ml for the next patients if the previous patient shows negative in the same group. The
initial TCI Ceprop was decreased by 0.5 ug/ml for the next patient if the previous patient
shows positive in the same group. All the patients were increased by 0.5 ug/ml stepwise at 4
min intervals until they showed LOC. An interval of 4 min was based on the pharmacokinetic
and pharmacodynamic (PK-PD) character of propofol in order to obtain the steady-state
effect-site concentrations (4; 5). An intravenous of 0.25 mg/Kg oxycodone and 0.6 mg/Kg
rocuronium were given after LOC to facilitate tracheal intubation.
Maintenance of anesthesia Anesthesia was maintained with propofol, remifentanil and
rocuronium during surgery. Ceprop was adjusted in stepwise of 0.5 ug/ml to keep the BIS
between 45 to 55 in two groups. The lowest Ceprop was 2.0 ug/ml to avoid intraoperative
awareness. Concentration for remifentanil was between 0.05 ug/Kg/min and 0.25 ug/Kg/ min
during surgery depend on the blood pressure. The maintenance doses of rocuronium was
0.15mg/Kg as required to maintain surgical paralysis (6). Patients with hypertension were
treated with 10 mg urapidil or 5 mg diltiazem i.v and hypotension was treated initially by
speeding Ringger's solution, infusion voluven, then decrease concentration of remifentanil by
0.05 ug/Kg/min until reach the lower limit of 0.05 ug/Kg/min and finally given 5mg ephedrine
i.v. 80 ug phenylephrine or 1mg metaraminol were then given if hypotension was remaining.
Postoperative management Anesthetics were stopped when the final surgical suture was done and
then 2-4mg/Kg of sugammadex was applied according to the train-of-four (TOF) ratio. The
duration between the time of discontinuation of anesthetics and the time of spontaneous
opening of eyes was defined as anesthesia emergency time. All patients received postoperative
patient-controlled epidural analgesia (PCEA) 0f 0.175% ropivacaine with 0.7ug/ml sufentanil.
The PCEA continuous infusion dose was 3-4 ml with patient-controlled bolus dose of 4-5ml
depend on the height and weight of patient.
Patients were transferred to PACU after extubation and stay at least 60 min there. In PACU,
pain intensity using numerical analogue score of 0-10, postoperative nausea, vomiting and
times of hypotension were evaluated and recorded at 30min, 60min and the time leave PACU.
